| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/02/2000 | EP0975760A1 Motilin homologs |
| 02/02/2000 | EP0975670A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy |
| 02/02/2000 | EP0975669A1 Calcitonin receptor-binding peptides |
| 02/02/2000 | EP0975595A1 Analogs of cocaine |
| 02/02/2000 | EP0975374A1 Radiometal-binding peptide analogues |
| 02/02/2000 | EP0975373A1 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents |
| 02/02/2000 | EP0975372A1 Contrast media for imaging of lung draining lymph nodes, administered through the lungs |
| 02/02/2000 | EP0774970A4 Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
| 02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
| 02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
| 02/01/2000 | US6019958 Polybasic compound having a molecular weight from about 500 daltons to about 15,000 daltons with a technetium-99m binding moiety covalently linked to the compound; and a polysulfated glycan having a molecular weight of at least about 1,000 |
| 02/01/2000 | US6019957 Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
| 01/26/2000 | EP0973902A1 Radioisotope concentrator methods and compositions |
| 01/26/2000 | EP0973554A1 Chelating agents |
| 01/26/2000 | EP0973553A2 Blood-pool carrier for lipophilic imaging agents |
| 01/26/2000 | EP0973552A2 Improvements in or relating to diagnostic/therapeutic agents |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/25/2000 | US6017913 Naphthylazo inhibition of amyloidosis |
| 01/25/2000 | US6017522 Segmented chelating polymers as imaging and therapeutic agents |
| 01/25/2000 | US6017514 Contacting a labeled antibody specific to an internal cell component but not with external ones with tissue of a mammal that has received therapy to kill malignant cells; measuring the binding where the internal component is an antigen |
| 01/25/2000 | US6017512 Cyclic hexapeptides not comprised of a disulfide bond covalently linked to a radiolabel e.g. technetium; scintigraphic imaging agents; radiodiagnosis and -therapy; antitumor,-carcinogenic and -diabetic agents; stability |
| 01/25/2000 | US6017511 Glycopeptide-chelator conjugates |
| 01/25/2000 | US6017510 Radioisotope of technetium-99m labeled leukocyte-binding peptides; scintographic imaging of sites of infection and inflammation; peptide derived from platelet factor 4, a bacterially-derived chemotactic peptide, fibrinopeptide |
| 01/25/2000 | US6017509 Cyclic hexapeptides not comprised of a disulfide bond covalently linked to a radiolabel e.g. technetium; scintigraphic imaging agents; radiodiagnosis and -therapy; antitumor,-carcinogenic and -diabetic agents; stability |
| 01/25/2000 | CA2002850C Technetium-99m complex for examining the renal function |
| 01/20/2000 | WO2000002587A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/20/2000 | WO2000002584A2 Cancer treatment methods using antibodies to aminophospholipids |
| 01/20/2000 | WO1999059633A8 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 01/20/2000 | WO1999054954A3 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
| 01/20/2000 | CA2331789A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/19/2000 | EP0972535A2 Inflatable member having elastic expansion with limited range |
| 01/19/2000 | EP0972528A2 Radioimmunoconjugate for use in human therapy and its preparation |
| 01/19/2000 | EP0972055A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 01/19/2000 | EP0971899A1 Hexahydroindenopyridine compounds having antispermatogenic activity |
| 01/19/2000 | EP0971748A2 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 01/19/2000 | EP0971747A2 Contrast agents |
| 01/19/2000 | EP0971740A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/19/2000 | EP0966227A4 Composition containing a radioactive component for treatment of vessel wall |
| 01/19/2000 | EP0664713B1 Therapeutic and diagnostic imaging compositions and methods |
| 01/18/2000 | US6015904 Stable reagents for the preparation of radio pharmaceuticals |
| 01/18/2000 | US6015897 For conjugation to ligand/antiligand pair and use in delivery of therapeutic or diagnostic agent to targeted site |
| 01/18/2000 | US6015561 Antigen binding peptides (abtides) from peptide libraries |
| 01/18/2000 | US6015544 Process for producing radiolabelled benzodiazepine receptor agents and composition containing the same |
| 01/18/2000 | US6015543 Diagnosis of tumors |
| 01/18/2000 | US6015542 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 01/18/2000 | US6015541 Radioactive embolizing compositions |
| 01/18/2000 | US6014969 Disposable package for use in aerosolized delivery of antibiotics |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001822A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 01/13/2000 | WO2000001414A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | WO1999030745A3 Dota-biotin derivatives |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336134A1 Use of texaphyrins in macrophage-mediated disease |
| 01/12/2000 | EP0970104A2 Steroid sulfamates, method for the production and use thereof |
| 01/12/2000 | EP0969879A2 THE USE OF MONONUCLEAR PHAGOCYTES IN $i(IN VIVO) IMAGING OF HYPOXIC/ISCHAEMIC TISSUE |
| 01/12/2000 | EP0969866A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 01/12/2000 | EP0686047B1 5-ht 1a ligands |
| 01/12/2000 | CN1241178A Novel compounds with analgesic effect |
| 01/11/2000 | US6013242 Tropane derivatives with selective binding to the serotonin reuptake transporters for treatment of mental illness and as intermediates in the formation of imaging diagnostic agents for depression |
| 01/11/2000 | US6013241 Use of porphyrin-complex or expanded porphyrin-complex compounds as an infarction localization diagnosticum |
| 01/06/2000 | WO2000000636A2 In vivo determination of metabolic function for use in therapy management |
| 01/06/2000 | WO2000000223A2 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 01/06/2000 | CA2336306A1 Indium photosensitizers for pdt |
| 01/06/2000 | CA2335616A1 In vivo determination of metabolic function for use in therapy management |
| 01/05/2000 | EP0968013A1 Coated implantable medical device |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0760683B1 Bile acid conjugates, derivatives thereof with metal complexes and related uses |
| 01/05/2000 | EP0570493B1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 01/05/2000 | DE19828732A1 Antiviral and anti-retroviral radio-immuno conjugates, for the treatment of viral infections |
| 01/04/2000 | US6010880 Inhibitors of human plasmin derived from the kunitz domains |
| 01/04/2000 | US6010846 Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
| 01/04/2000 | US6010681 Biodegradable blood-pool contrast agents |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | US6010679 Transition metal radionucleolide; contrast agents for diagnosing cardiovascular disorders, cancer |
| 01/04/2000 | US6010445 Radioactive medical device and process |
| 12/29/1999 | WO1999067284A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 12/29/1999 | WO1999067205A1 Novel compounds useful in pain management |
| 12/29/1999 | WO1999067204A1 Novel compounds |
| 12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | EP0966975A2 Diagnostic agents for pancreatic exocrine function |
| 12/29/1999 | EP0966428A1 PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-bis 2-HYDROXY-1- (HYDROXYMETHYL)ETHYL]-5- (2-HYDROXY-1-OXOPROPYl)AMINO]-2,4,6- TRIIODO-1,3-BENZENDICARBOXAMIDE |
| 12/29/1999 | EP0966227A1 Composition containing a radioactive component for treatment of vessel wall |
| 12/29/1999 | CN1239958A Macrocyclic metal complex carboxylic acids, use and method for production thereof |
| 12/29/1999 | CN1239895A Radiopharmaceuticals for imaging infection and inflammation |
| 12/29/1999 | CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | CA2335528A1 Novel compounds |
| 12/29/1999 | CA2335493A1 Novel compounds useful in pain management |
| 12/29/1999 | CA2328457A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 12/28/1999 | US6008319 A permeability enhancing peptide that is free of cytokine activity and is joined to a delivery vehicle that targets tumors; therapy for increasing uptake of antitumor agents or tumor imaging agents |
| 12/28/1999 | US6007817 Vasopermeability enhancing immunoconjugates |
| 12/28/1999 | US6007792 Chelate compounds labeled with technetium-99m, rhenium-186, or rhenium-188; tumor imaging |
| 12/28/1999 | US6006754 Method for measuring fat digestion and absorption formulation to aid in measuring fat absorption |
| 12/28/1999 | CA2021173C Radioactive diagnostic agent |
| 12/23/1999 | WO1999065532A1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement |
| 12/23/1999 | WO1999065467A1 Method for introducing a chemical agent into the systemic circulation |
| 12/22/1999 | EP0928204A4 Measurement of liquid phase gastric emptying |
| 12/22/1999 | EP0515386B1 Glycoalkaloids |
| 12/22/1999 | CN1238991A Sol preparation of rhenium nuclein labeled iodinated oil and its preparing process and application |
| 12/21/1999 | US6005083 Substituted metal chelating compounds for imaging and therapy |